Bitcoin climbs to record $123,000 as US to debate crypto rules
Bitcoin scaled a record high of $123,153.22 before pulling back slightly to trade 2.4% higher around $122,000.
Later in the day, the US House of Representatives will debate a series of bills to provide the digital asset industry with the nation's regulatory framework it has long demanded.
Those demands have resonated with US President Donald Trump, who has called himself the "crypto president" and urged policymakers to revamp rules in favour of the industry.
"It's riding a number of tailwinds at the moment," said IG market analyst Tony Sycamore, citing strong institutional demand, expectations of further gains and support from Trump as reasons for the bullishness.
"It's been a very, very, strong move over the past six or seven days and it's hard to see where it stops now. It looks like it can easily have a look at the $125,000 level," he said.
The surge in bitcoin, which is up 30% so far this year, has sparked a broader rally across other crypto currencies over the past few sessions even in the face of Trump's chaotic tariff policies.
Ether, the second-largest token, scaled a more than five-month peak of $3,059.60, while XRP and Solana gained about 3% each.
The sector's total market value has swelled to about $3.81 trillion, according to data from CoinMarketCap.
"What we find interesting and are watching closely are the signs that bitcoin is now being seen as a long-term reserve asset, not just by retail investors and institutions but even some central banks," said Gracie Lin, crypto exchange OKX's Singapore CEO.
"We're also seeing increasing participation from Asia-based investors, including family offices and wealth managers. These are strong signs of bitcoin's role in the global financial system and the structural shift in how it is perceived, suggesting that this isn't just another hype-driven rally," Lin said.
Earlier this month, Washington declared the week of July 14 as "crypto week," during which members of Congress are set to vote on the Genius Act, the Clarity Act, and the Anti-CBDC Surveillance State Act.
The most significant bill is the Genius Act, which would create federal rules for stablecoins.
Elsewhere, prices of crypto stocks and exchange traded funds advanced.
In U.S. premarket trading, shares of crypto exchange Coinbase surged 1.7%, while bitcoin holder Strategy climbed 3.3%. Crypto miner Mara Holdings jumped 4.6%.
Hong Kong listed spot bitcoin ETFs launched by China AMC , Harvest and Bosera all hit record highs.
Reuters
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
30 minutes ago
- Zawya
IVD Medical Holding Limited (01931.HK): Officially launched the application for the US stablecoin license and accelerated the landing of the IVDNewCo Exchange ecosystem
HONG KONG SAR - Media OutReach Newswire - 21 July 2025 – IVD Medical Holding Limited( - Forward-looking layout of the historical opportunity of the US "Genius Act", the IVDD stablecoin plan is gathering momentum to set sail and build a new global infrastructure for medical innovative drugs RWA! In the wave of deep integration of global digital finance and medical innovation, IVD Medical Holding Limited( took the lead in building the "NewCo+RWA" Web3 exchange ecosystem (IVDNewCo Exchange) with the construction of medical innovative drugs high-tech assets as the core and the supporting stablecoin "IVDDollar" (IVDD) plan as the core strategy, leading the digital revolution of global medical innovation assets. On July 20, 2025, the Board of Directors is pleased to announce that the US subsidiary carrying the Group's aforementioned core strategic mission has landed, and the IVDNewCo Exchange ecosystem has officially landed on the international financial stage. The company released the latest announcement today, officially announcing two milestones: the US wholly-owned subsidiary IVD GROUP INC. has completed registration, and the Group has officially started the process of submitting a stablecoin license application to the US regulator through the subsidiary; at the same time, the Web3 exchange ecosystem with medical innovative drug NewCo assets as the core - IVDNewCo Exchange and its supporting stablecoin IVDD have entered a substantive stage. This strategic move not only marks the Group's leading position in the field of compliant digital finance for medical innovative drugs, but also heralds a revolutionary breakthrough in the global medical asset liquidity and value conversion model. 1. Strategic opportunities under global regulatory resonance On July 18, 2025, local time, US President Trump signed the "Guidance and Establishment of the United States Stablecoin National Innovation Act" (hereinafter referred to as the "Genius Act") at the White House, establishing the legal status of stablecoins as "digital dollars". The implementation of this bill, together with the Stablecoin Ordinance of the Hong Kong Special Administrative Region, which will take effect on August 1, forms a regulatory synergy between the East and the West, and jointly builds the compliance cornerstone of the global stablecoin market. The report of the China Banking Research Institute pointed out that currently 99% of the world's stablecoins are anchored to US dollar assets, and US Treasury bonds have become the core choice of stablecoin reserve assets due to their low risk and high liquidity. In this context, the Group proactively laid out the application for the US stablecoin license, and on July 20 officially announced that the US subsidiary had initiated the process of submitting application materials to regulatory agencies such as the US SEC and CFTC, becoming one of the very few listed companies in the Hong Kong stock market that has completed the "Hong Kong + US" dual hub compliance architecture layout. The strategic layout of the Group is deeply in line with the global regulatory trend. By establishing the US subsidiary IVD GROUP INC., we not only meet the strict requirements of the "Genius Act" for 100% reserve asset coverage and independent auditing of stablecoin issuers, but also rely on the sandbox mechanism of the Hong Kong "Stablecoin Ordinance" to build a cross-regional regulatory endorsement system. This dual hub model provides the IVDNewCo Exchange ecosystem with globally rare compliant liquidity support, enabling the Group to establish a first-mover advantage in the "Hong Kong Stock Stablecoin Concept Sector". 2. Technological Innovation: "NewCo+RWA+Stablecoin" Reconstructs the Value Chain of Medical Innovative Drug Assets The core breakthrough of the IVDNewCo Exchange ecosystem lies in the deep integration of Web3 technology and medical innovative drug assets. Relying on the commercial network covering 1,674 tertiary hospitals in China and the ability to acquire high-quality NewCo assets around the world, the Group has created the world's first RWA (real world asset) tokenization platform focusing on medical innovative drugs. The platform achieves the following innovations through blockchain technology: 1). Asset tokenization: converting innovative drug assets such as ADC drugs, bi-antibody therapy, and cell gene therapy in the clinical stage into tradable and divisible digital certificates to break through the liquidity bottleneck of traditional medical assets; 2). Compliance financial infrastructure: establish an underlying architecture to support the issuance, trading and settlement of IVDD stablecoins, ensuring that each $1 stablecoin corresponds to ultra-short-term U.S. Treasury bonds and other low-risk assets, meeting the U.S. SEC's "1:1 redeemable" requirements; 3). Coin-stock linkage mechanism: coordinate with Nasdaq's dual primary listing plan to explore the compound value creation model of "digital assets + traditional equity" to attract two-way inflows of traditional medical capital and crypto-native funds. The implementation of this technical architecture has been strongly supported by industry data. Public information shows that the current global innovative drug market has exceeded US$1.2 trillion, and China accounts for 6% of the market with a scale of RMB 450 billion, with an annual compound growth rate of 20.3%. Through the RWA platform, the Group expects to significantly improve the financing efficiency of innovative drug assets, while lowering the entry threshold for investors, allowing small and medium-sized investors around the world to participate in the medical innovation field that was originally limited to institutional investment. 3. Ecological synergy: creating a new paradigm for medical finance The Group's strategic advancement has always followed the three-dimensional path of "regulatory compliance-technological innovation-ecological synergy". In the United States, IVD GROUP INC.'s license application strictly follows the requirements of the Genius Act for reserve asset transparency, anti-money laundering (AML) and network security. Its technical system has passed a third-party security audit to ensure that smart contracts are free of loopholes; in Hong Kong, the Group will actively promote participation in the HKMA's stablecoin sandbox program to test reserve asset management and cross-border payment scenarios, laying the foundation for license application. More importantly, the implementation of the IVDNewCo Exchange ecosystem is reshaping the value chain of innovative medical drugs. Under the traditional model, the research and development of innovative drugs requires a cycle of up to 10 years, and 80% of the funds are concentrated in the clinical stage. Through the RWA platform, the Group can monetize clinical-stage assets in advance, provide pharmaceutical companies with low-cost financing channels, and provide investors with dynamic returns linked to the progress of drug development. For example, an ADC drug in Phase II clinical trials can attract global capital participation through tokenization, and its development progress data will be uploaded to the chain in real time to ensure that investors' rights and interests are transparent and traceable. 4. Industry Impact and Future Outlook The Group's strategic initiatives have attracted widespread attention from the capital market and the industry. After the announcement on the 17th, IVD Medical's share price opened sharply higher on the 18th, closing at HK$2.95, up 20.41% throughout the day, with a turnover exceeding HK$9.4886 million and a market value of HK$4.783 billion. Behind the market data is investors' strong confidence in the cross-border integration of "NewCo+RWA+stablecoin". Looking ahead, the Group will continue to deepen the three strategic directions of compliance expansion, technology deepening and ecological integration. Against the backdrop of the global low interest rate environment and the surge in demand for medical innovation, it will use Web3 technology as a bridge to connect traditional medical capital and digital financial innovation. We firmly believe that through compliance layout and technological innovation, the IVDNewCo Exchange ecosystem will become a value amplifier for global innovative medical drug assets, creating a win-win situation for patients, pharmaceutical companies and investors. Hashtag: #IVDMedicalHoldingLimited The issuer is solely responsible for the content of this announcement. IVD Medical Holding Limited
Crypto Insight
an hour ago
- Crypto Insight
GENIUS Act blocks Big Tech, banks from dominating stablecoins: Circle exec
The GENIUS Act contains a little-noticed clause that prevents technology giants and Wall Street behemoths from dominating the stablecoin market, according to Circle Chief Strategy Officer Dante Disparte. 'The GENIUS Act has what I'd like to call — just for my own legacy sake — a Libra clause,' Disparte told the Unchained podcast on Saturday. Any non-bank that wants to mint a dollar-pegged token must spin up 'a standalone entity that looks more like Circle and less like a bank,' clear antitrust hurdles and face a Treasury Department committee with veto power over the launch. Banks don't get a free pass either. Lenders that issue a stablecoin must house it in a legally separate subsidiary and keep the coins on a balance sheet that carries 'no risk-taking, no leverage, no lending,' Disparte noted. That structure is even 'more conservative' than the deposit-token models JPMorgan and others have floated. 'It creates clear rules that I think in the end the biggest winners are the US consumers and market participants and frankly the dollar itself,' he added. GENIUS Act passes with bipartisan backing Passed last week with more than 300 House votes, including support from 102 Democrats, the Guiding and Establishing National Innovation for US Stablecoins (GENIUS) Act gives the dollar 'rules-based' firepower in the global digital-currency race, Disparte argued. 'Crypto is finally getting what it wanted: legitimization, a path for legal and regulatory clarity in the United States and an opportunity to compete,' he said. The bill preserves the patchwork of state money-transmitter laws for issuers under a $10 billion threshold but demands a national trust-bank charter once assets breach that level. Notably, the law bans interest-bearing stablecoins, pushes rigorous disclosure standards and introduces criminal penalties for unbacked 'stable' tokens. Terra-style experiments are 'gone,' Disparte said. However, critics argue the ban on yield could stunt consumer adoption and hand an advantage to overseas issuers. Disparte claimed that yield 'is a secondary-market innovation' better delivered by decentralized finance protocols once the base layer is rock-solid. DeFi gains edge as GENIUS bans yields The GENIUS Act's ban on yield-bearing stablecoins could redirect investor demand toward Ethereum-based decentralized finance (DeFi) platforms. With no interest incentives left in stablecoins, DeFi becomes the primary option for generating passive income onchain, according to analysts like Nic Puckrin and CoinFund's Christopher Perkins, who predicted that 'stablecoin summer' may now evolve into 'DeFi summer.' The ban is especially significant for institutional investors. Unlike retail users, financial institutions have fiduciary duties to generate returns, making yield opportunities essential. Analysts suggest this could lead to a surge in institutional capital flowing into DeFi, particularly on Ethereum, which dominates total value locked in the sector. Source:
Gulf Today
2 hours ago
- Gulf Today
For California, a summer of discontent
California is having a bummer of a political summer. With the state under daily siege by the Trump administration, Los Angeles occupied by federal troops and our gallivanting governor busy running for president, is it really any surprise? A recent UC Irvine poll found that residents, by a 2-to-1 margin, believe California is headed on the wrong track, a mood consistent with other gauges of Golden State grumpiness. Why the sad faces? 'We are so divided as a country that people feel like there's no common purpose and the other guys are out there about to do mayhem to the things that they believe in,' said Jon Gould, dean of UC Irvine's School of Social Ecology. 'Number two, there is a substantial portion of people who feel that their economic situation is worse than it was four years ago, two years ago, one year ago.' Gov. Gavin Newsom also gets some credit, er, blame for the state's darkened disposition. A poll conducted by UC Berkeley's Institute of Governmental Studies found California voters have little faith in their chief executive as he rounds the turn toward his final year in office. (Which may be one reason Newsom would rather spend time laying the groundwork for a 2028 White House bid.) Only 14% of voters surveyed had 'a lot' of trust in Newsom to act in the best interests of the California public, while another 28% trusted him 'somewhat.' Fifty-three percent had no trust in the governor, or only 'a little.' Not a strong foundation for a presidential campaign, but Potomac fever is a powerful thing. The Democratic-run Legislature fared about the same in the Berkeley survey. Forty-four percent of respondents had either a lot or some degree of trust in Sacramento lawmakers — not a great look, but a number that positively shines compared to attitudes toward California's tech companies and their leaders as they increasingly try to spread their overweening influence to politics. Only 4% had a lot of trust in the companies acting in the best interest of the California public; nearly six in 10 did not trust them at all. (There was similarly little faith in business groups.) But it's not just the state's leaders and institutions that fail to engender much trust or goodwill. A survey by the nonpartisan Public Policy Institute of California found residents have also soured on the three branches of the federal government. Fewer than a third of Californians expressed approval for President Donald Trump and the conservative-leaning Supreme Court. Just 2 in 10 Californians approved of the job Congress is doing. Some of that is colored by partisan attitudes. Registered Democrats make up the largest portion of the electorate and, obviously, most aren't happy with the GOP stranglehold on Washington. But that distrust transcended red and blue loyalties. Overall, 8 in 10 adults said they do not fully trust the federal government to do what is right. A nearly identical percentage said they trust the government to do what is right only some of the time. That, too, is part of a long-standing pattern. 'It's a concern, but it's not a new concern,' said Mark Baldassare, who directs research for the Public Policy Institute. 'It's been around in some form for decades.' Back in 1958, when the National Election Study first asked, about three-quarters of Americans trusted the federal government to do the right thing almost always or most of the time — a level of faith that, today, sounds like it comes from people in another galaxy. Starting in the 1960s, with the escalation of the Vietnam War, and continuing through the Watergate scandal of the 1970s, that trust has steadily eroded. The last time the Pew Research Center asked the question, in the spring of 2024, just 35% of Democrats and Democratic-leaning independents nationwide said they trusted the federal government just about always or most of the time. That compared to just 11% of Republicans and Republican leaners. What's new — and perhaps most troubling — in the recent batch of opinion surveys are growing fears for the state of our democracy.
